Please see the following funding opportunity announcements from the National Institute on Drug Abuse:
This Funding Opportunity Announcement (FOA) supports research on the effects of HIV and addictive substances, acting independently or synergistically on blood brain barrier (BBB) structure and function and the involvement of these effects in HIV associated neuropathology.
Application Due Date: August 10, 2023
------------
Ex Vivo Models for Studies at the Intersection of HIV and Poly-Substance Use (R01 Clinical Trial Not Allowed) RFA-DA-24-001.
This Notice of Funding Opportunity (NOFO) invites grant applications aimed at elucidating pathophysiological mechanisms of HIV-associated neurological disorders (HAND) using ex vivo culturing platforms in the presence of addictive substances, with emphasis on genetic, epigenetic and neuroimmune mechanisms at the single cell to neural circuit levels.
Application Due Date: August 10, 2023
----------------
Advancing Psychedelics Research for Treating Addiction (R01 Clinical Trial Not Allowed) RFA-DA-24-028
This notice of funding opportunity (NOFO) will support research to improve our understanding of psychedelic drug mechanisms in the context of substance use disorders (SUDs). This NOFO will also support the design and synthesis of chemical biology tools and probes to aid basic research on psychedelics and their translational pharmacology.
Note: This NOFO requires a Plan for Enhancing Diverse Perspectives (PEDP), which will be assessed as part of the scientific and technical peer review evaluation.
Application Due Date: November 02, 2023
Other NIDA Funding Opportunities: https://nida.nih.gov/funding/nida-funding-opportunities
------
The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services TO UNSUBSCRIBE: send email to listserv@list.nih.gov Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L
No comments:
Post a Comment